CYH vs. FULC, TRDA, CCCC, EDIT, TSHA, TBPH, VYGR, ADPT, SLRN, and RVNC
Should you be buying Community Health Systems stock or one of its competitors? The main competitors of Community Health Systems include Fulcrum Therapeutics (FULC), Entrada Therapeutics (TRDA), C4 Therapeutics (CCCC), Editas Medicine (EDIT), Taysha Gene Therapies (TSHA), Theravance Biopharma (TBPH), Voyager Therapeutics (VYGR), Adaptive Biotechnologies (ADPT), Acelyrin (SLRN), and Revance Therapeutics (RVNC). These companies are all part of the "medical" sector.
Fulcrum Therapeutics (NASDAQ:FULC) and Community Health Systems (NYSE:CYH) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk, media sentiment, dividends and community ranking.
Fulcrum Therapeutics has a beta of 2.35, suggesting that its stock price is 135% more volatile than the S&P 500. Comparatively, Community Health Systems has a beta of 1.55, suggesting that its stock price is 55% more volatile than the S&P 500.
Community Health Systems received 450 more outperform votes than Fulcrum Therapeutics when rated by MarketBeat users. However, 64.63% of users gave Fulcrum Therapeutics an outperform vote while only 53.27% of users gave Community Health Systems an outperform vote.
89.8% of Fulcrum Therapeutics shares are owned by institutional investors. Comparatively, 85.0% of Community Health Systems shares are owned by institutional investors. 4.1% of Fulcrum Therapeutics shares are owned by insiders. Comparatively, 9.9% of Community Health Systems shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Fulcrum Therapeutics has higher earnings, but lower revenue than Community Health Systems. Fulcrum Therapeutics is trading at a lower price-to-earnings ratio than Community Health Systems, indicating that it is currently the more affordable of the two stocks.
Community Health Systems has a net margin of -0.99% compared to Community Health Systems' net margin of -3,470.05%. Fulcrum Therapeutics' return on equity of -5.51% beat Community Health Systems' return on equity.
Fulcrum Therapeutics presently has a consensus price target of $14.33, indicating a potential upside of 89.85%. Community Health Systems has a consensus price target of $4.05, indicating a potential upside of 12.19%. Given Community Health Systems' stronger consensus rating and higher possible upside, equities analysts clearly believe Fulcrum Therapeutics is more favorable than Community Health Systems.
In the previous week, Fulcrum Therapeutics had 28 more articles in the media than Community Health Systems. MarketBeat recorded 36 mentions for Fulcrum Therapeutics and 8 mentions for Community Health Systems. Fulcrum Therapeutics' average media sentiment score of 0.29 beat Community Health Systems' score of 0.26 indicating that Community Health Systems is being referred to more favorably in the news media.
Summary
Fulcrum Therapeutics and Community Health Systems tied by winning 9 of the 18 factors compared between the two stocks.
Get Community Health Systems News Delivered to You Automatically
Sign up to receive the latest news and ratings for CYH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CYH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Community Health Systems Competitors List
Related Companies and Tools
